(2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid

Term ID

CHEBI:151646

Synonyms

2-deoxy-2-sulfoamino-alpha-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronic acid
GlcNS(a1-4)b-GlcA

Definition

References

glygen:G52523DM
glytoucan:G52523DM

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid

Phenotype where environments contain (2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid

Phenotype modified by environments containing (2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid

Phenotype affecting (2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid

Human Disease Model